Cerity Partners’s Inogen INGN Stock Holding History

Cerity Partners’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	31,553 +17,703	+128%	+$117K	﹤0.01%	3043
2026 Q1	$85.6K	Buy	+13,850	New	+$85.5K	﹤0.01%	3040

Other funds holding INGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerity Partners's INGN Position: Q2 2026 in Review

Cerity Partners increased its Inogen (INGN) stake by 128% in Q2 2026, buying an estimated $117K and bringing the position to 31,553 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #3043.

Cerity Partners first reported a position in INGN in Q1 2026 and has held it in 2 quarters since. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

Cerity Partners held 31,553 shares of Inogen worth $204K as of Q2 2026.
Cerity Partners bought 17,703 Inogen shares in Q2 2026, an estimated $117K.
Inogen made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3043 holding.
Cerity Partners first reported a position in Inogen in Q1 2026 and has held it in 2 quarters since.
129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.